Experience

Ribon Therapeutics

• United States
• Biotechnology Research
• 1 - 100 Employee

• Associate Director

  • Mar 2023 - Present

• Principal Scientist

  • Feb 2021 - May 2023

• Senior Scientist

  • Jun 2017 - Feb 2021



Institute for Applied Cancer Science at MD Anderson Cancer Center

• Houston, Texas Area

• Institute Research Scientist

  • Jun 2015 - Jun 2017

  Senior scientist for the IACS-010759 (OXPHOS inhibitor) program and its translation into AML (acute myeloid leukemia) phase I clinical trial Leading target validation activities for exploratory oncology targets currently under investigation Developed assays to enable immune-metabolic and stemness characterization of cancer cell lines and primary cells for multiple lead programs Trained and managed associate scientists Senior scientist for the IACS-010759 (OXPHOS inhibitor) program and its translation into AML (acute myeloid leukemia) phase I clinical trial Leading target validation activities for exploratory oncology targets currently under investigation Developed assays to enable immune-metabolic and stemness characterization of cancer cell lines and primary cells for multiple lead programs Trained and managed associate scientists



MD Anderson Cancer Center

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Postdoctoral Fellow

  • Feb 2010 - Jun 2015

  Co-developed the cancer metabolism assay platform in the Mills laboratory Developed projects focusing on metabolic adaptation in breast cancer progression via in vivo and in vitro models Collaborated with industry scientists on drug development programs focusing on lactate biology and generated critical data that contributed to GO/No-GO decisions. Integral member of the team that identified metabolic heterogeneity in breast cancer subtypes and discovered a novel metabolic… Show more Co-developed the cancer metabolism assay platform in the Mills laboratory Developed projects focusing on metabolic adaptation in breast cancer progression via in vivo and in vitro models Collaborated with industry scientists on drug development programs focusing on lactate biology and generated critical data that contributed to GO/No-GO decisions. Integral member of the team that identified metabolic heterogeneity in breast cancer subtypes and discovered a novel metabolic biomarker for triple-negative breast cancer that predicts response to neo-adjuvant chemotherapy Collaborated with N3D Biosciences Inc. scientists to develop a novel application of their 3-dimensional culture system suitable for drug screening Trained research students and associates both technically and scientifically Show less Co-developed the cancer metabolism assay platform in the Mills laboratory Developed projects focusing on metabolic adaptation in breast cancer progression via in vivo and in vitro models Collaborated with industry scientists on drug development programs focusing on lactate biology and generated critical data that contributed to GO/No-GO decisions. Integral member of the team that identified metabolic heterogeneity in breast cancer subtypes and discovered a novel metabolic… Show more Co-developed the cancer metabolism assay platform in the Mills laboratory Developed projects focusing on metabolic adaptation in breast cancer progression via in vivo and in vitro models Collaborated with industry scientists on drug development programs focusing on lactate biology and generated critical data that contributed to GO/No-GO decisions. Integral member of the team that identified metabolic heterogeneity in breast cancer subtypes and discovered a novel metabolic biomarker for triple-negative breast cancer that predicts response to neo-adjuvant chemotherapy Collaborated with N3D Biosciences Inc. scientists to develop a novel application of their 3-dimensional culture system suitable for drug screening Trained research students and associates both technically and scientifically Show less



The University of Texas Health Science Center at Houston (UTHealth Houston)

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Ph.D. Student

  • Sep 2004 - Oct 2009

  • Discovered a novel tumor suppressor complex that is impaired in glioblastoma multiforme (GMB) tumors and leads to a highly invasive phenotype • Developed a model for in vivo and in vitro isolation and characterization of highly invasive GBM cells • Established quantitative assays for validation of tumor suppressor complexes in human GBM patient tumors • Collaborated with N3D Biosciences Inc. to develop a novel 3-dimensional magnetic cell culture technique • Trained PhD students… Show more • Discovered a novel tumor suppressor complex that is impaired in glioblastoma multiforme (GMB) tumors and leads to a highly invasive phenotype • Developed a model for in vivo and in vitro isolation and characterization of highly invasive GBM cells • Established quantitative assays for validation of tumor suppressor complexes in human GBM patient tumors • Collaborated with N3D Biosciences Inc. to develop a novel 3-dimensional magnetic cell culture technique • Trained PhD students and research associates Show less • Discovered a novel tumor suppressor complex that is impaired in glioblastoma multiforme (GMB) tumors and leads to a highly invasive phenotype • Developed a model for in vivo and in vitro isolation and characterization of highly invasive GBM cells • Established quantitative assays for validation of tumor suppressor complexes in human GBM patient tumors • Collaborated with N3D Biosciences Inc. to develop a novel 3-dimensional magnetic cell culture technique • Trained PhD students… Show more • Discovered a novel tumor suppressor complex that is impaired in glioblastoma multiforme (GMB) tumors and leads to a highly invasive phenotype • Developed a model for in vivo and in vitro isolation and characterization of highly invasive GBM cells • Established quantitative assays for validation of tumor suppressor complexes in human GBM patient tumors • Collaborated with N3D Biosciences Inc. to develop a novel 3-dimensional magnetic cell culture technique • Trained PhD students and research associates Show less



Columbia University

• United States
• Higher Education
• 700 & Above Employee

• Master of Science

  • Jun 2002 - Jun 2004

  • Laboratory manager for the MESA (multi-ethnic study of atherosclerosis) multi-center clinical study. • Responsible for all patient sample related assays • Supported biology efforts for studies of the molecular mechanisms of atherosclerosis • Developed immunohistochemistry and primary cell culture methods • Laboratory manager for the MESA (multi-ethnic study of atherosclerosis) multi-center clinical study. • Responsible for all patient sample related assays • Supported biology efforts for studies of the molecular mechanisms of atherosclerosis • Developed immunohistochemistry and primary cell culture methods



Universidad Peruana Cayetano Heredia

• Peru
• Higher Education
• 700 & Above Employee

• Visiting Researcher

  • Jun 2000 - Aug 2000

  Summer project in the laboratory of Dr. Ana Prada at the Instituto de Enfermedades Tropicales of the Universidad Cayetano Heredia. Focus: microbiology, bacteria isolation and identification techniques, manuscript preparation Summer project in the laboratory of Dr. Ana Prada at the Instituto de Enfermedades Tropicales of the Universidad Cayetano Heredia. Focus: microbiology, bacteria isolation and identification techniques, manuscript preparation